When cannabichromene is subject to changes in the environment such as an alteration in light, cannabicyclol (CBL) is formed. Although there hasn’t been too much research conducted on cannabicyclol, there is still a belief that it has some therapeutic properties that can make it of value in the medicinal field. CBL is found in a lot of different strain of marijuana, but scientists are still unsure exactly how it affects the human organs.
CBL is commonly found in cannabis that is fairly old or has been sitting for a long period of time. Cannabicyclol is sometimes referred to as cannabipinol. The vast majority of the researches made so far focused on the chemical structure of CBL. Several studies had a negative outcome when CBL was tested for its medical uses. These results have led to the fact that CBL just doesn’t have the same medical properties that CBD and THC contain.
There was a study in 1976 that was conducted with rabbits and it showed that 1mg per kg of body weight had no serious results. In larger doses, CBL even caused convulsions and death. Cannabis that dates back to 2700 B.C. appear to contain much higher concentrations of CBL. CBL does not produce the same psychoactive effects that THC will provide. Because of the failed studies in the past on CBL, most scientists continue to focus their attention on THC and CBD. One of the big differences between CBL and THC is that while they do have similar formulas, CBL has no double bonds, whereas THC does.
This is what gives THC its psychoactive effects on the user. CBL was once researched to see if it could reduce prostaglandin production, which controls muscle contractions, yet it was not reported to have any effect.